Irving, Texas
Phase 1 colorectal cancer trials in Irving, TX
15 Phase 1 colorectal cancer studies are recruiting participants at sites in Irving as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Irving at a glance
- 15 studies are recruiting at a site in Irving.
- By phase: Phase 1 (10), Phase 1/2 (5).
- By sponsor: industry (15).
- Most recent update to one of these records: November 13, 2026.
Studies recruiting in Irving
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Next Oncology - Dallas
- Registry record
- NCT07488676 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- NEXT Texas LLC - Dallas
- Registry record
- NCT07503808 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- NEXT Dallas
- Registry record
- NCT07397338 · updated
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Immunome, Inc.
- Study site
- NEXT Dallas
- Registry record
- NCT07578571 · updated
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Inc
- Study site
- NEXT Oncology Dallas
- Registry record
- NCT07094204 · updated
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sutro Biopharma, Inc.
- Study site
- NEXT Oncology Dallas
- Registry record
- NCT07807345 · updated
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Next Oncology Dallas /ID# 284346
- Registry record
- NCT07807956 · updated
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Avacta Life Sciences Ltd
- Study site
- NEXT Oncology
- Registry record
- NCT07454642 · updated
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- NEXT Dallas - Oncology Department
- Registry record
- NCT07535112 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #73
- Registry record
- NCT05176483 · updated
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- NEXT Dallas
- Registry record
- NCT06128551 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- NEXT Oncology Dallas
- Registry record
- NCT06445062 · updated
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ArriVent BioPharma, Inc.
- Study site
- NEXT Dallas
- Registry record
- NCT07066657 · updated
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Next Oncology Dallas /ID# 276254
- Registry record
- NCT05005403 · updated
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- MBrace Therapeutics
- Study site
- NEXT, Dallas
- Registry record
- NCT07145255 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Irving, TX on ClinicalTrials.gov.
Ask about studies near Irving
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
119 studies recruiting across 18 cities.
Houston
86 studies recruiting.
San Antonio
43 studies recruiting.
Dallas
30 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections